These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1643242)

  • 1. Reduction of myocardial damage by cloricromene during ischemia-reperfusion in the rabbit.
    Milei J; Llesuy S; Ferreira R; Grana D; Prosdocimi M; Boveris A
    Cardioscience; 1992 Jun; 3(2):97-105. PubMed ID: 1643242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cloricromene on ischemia-reperfusion myocardial damage in the rabbit.
    Milei J; Ferreira R; Grana D; Cirillo R; Llesuy S; Prosdocimi M
    Cardiology; 1992; 81(2-3):89-99. PubMed ID: 1286483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of cloricromene in ischemic reperfused myocardium.
    Milei J; Ferreira R; Grana D; Beigelman R; Cirillo R
    Cardiology; 1994; 84(4-5):284-91. PubMed ID: 8187114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of the anti-ischaemic effects of cloricromene from its anti-platelet activity.
    Lidbury PS; Cirillo R; Vane JR
    Br J Pharmacol; 1993 Sep; 110(1):275-80. PubMed ID: 8220889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ischemia-reperfusion experimental model in the rabbit: ligation of the circumflex coronary artery versus ligation of the anterior descending coronary artery].
    Grana D; Ferreira R; Beigelman R; Llesuy S; Milei J
    Rev Esp Cardiol; 1994 Aug; 47(8):544-9. PubMed ID: 7973016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
    Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloricromene reduces myocardial infarct size in rabbits when administered during the early reperfusion period.
    Zvara DA; Galaska HJ; Castellano VP; Vinten-Johansen J; Royster RL; Williams MW; Murphy BA; Kim EJ
    Anesth Analg; 1997 Feb; 84(2):266-70. PubMed ID: 9024013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of myocardial function by trifluoperazine, a calmodulin antagonist, after acute coronary artery occlusion and coronary revascularization.
    Otani H; Engelman RM; Rousou JA; Breyer RH; Clement R; Prasad R; Klar J; Das DK
    J Thorac Cardiovasc Surg; 1989 Feb; 97(2):267-74. PubMed ID: 2915562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do N-acetylcystein, beta-glucan, and coenzyme Q10 mollify myocardial ischemia-reperfusion injury?
    Bolcal C; Yildirim V; Doganci S; Sargin M; Aydin A; Kuralay E; Ozal E; Demirkilic U; Oz BS; Sayal A; Tatar H
    Heart Surg Forum; 2007; 10(3):E222-7. PubMed ID: 17599896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of effects of verapamil and those of nicardipine on myocardial ischemia and reperfusion injury: a study in an in situ rabbit model].
    Furuya M; Yoshida K
    Masui; 1999 Oct; 48(10):1074-82. PubMed ID: 10554498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emulsified isoflurane produces cardiac protection after ischemia-reperfusion injury in rabbits.
    Rao Y; Wang YL; Zhang WS; Liu J
    Anesth Analg; 2008 May; 106(5):1353-9, table of contents. PubMed ID: 18420844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotective effects of simvastatin on reversing electrical remodeling induced by myocardial ischemia-reperfusion in normocholesterolemic rabbits.
    Ding C; Fu XH; He ZS; Chen HX; Xue L; Li JX
    Chin Med J (Engl); 2008 Mar; 121(6):551-6. PubMed ID: 18364145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloricromene reduces infarct size and alters postischaemic blood flow defects in dog myocardium.
    Groban L; Zvara DA; Deal DD; Vernon JC; Flye CW; Ma XL; Vinten-Johansen J
    Clin Exp Pharmacol Physiol; 1998 Jun; 25(6):417-23. PubMed ID: 9673816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in vessel ultrastructure during ischemia and reperfusion of rabbit hindlimb: implications for therapeutic intervention.
    Aliev G; Cirillo R; Salvatico E; Paro M; Prosdocimi M
    Microvasc Res; 1993 Jul; 46(1):65-76. PubMed ID: 8412853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of desflurane-induced preconditioning following ischemia-reperfusion on nitric oxide release in rabbits.
    Tsai SK; Lin SM; Huang CH; Hung WC; Chih CL; Huang SS
    Life Sci; 2004 Dec; 76(6):651-60. PubMed ID: 15567190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial protection of insulin and potassium in a porcine ischemia-reperfusion model.
    Oates A; Nubani R; Smiley J; Kistler L; Hughey S; Theiss P; Perez-Tamayo RA; Eiferman D; Lonchyna V; Higgins RS
    Surgery; 2009 Jul; 146(1):23-30. PubMed ID: 19541007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of heart transplant injury and graft coronary artery disease after prolonged organ ischemia by selective protein kinase C regulators.
    Tanaka M; Gunawan F; Terry RD; Inagaki K; Caffarelli AD; Hoyt G; Tsao PS; Mochly-Rosen D; Robbins RC
    J Thorac Cardiovasc Surg; 2005 May; 129(5):1160-7. PubMed ID: 15867794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of myocardial reperfusion injury by aprotinin after regional ischemia and cardioplegic arrest.
    Khan TA; Bianchi C; Voisine P; Feng J; Baker J; Hart M; Takahashi M; Stahl G; Sellke FW
    J Thorac Cardiovasc Surg; 2004 Oct; 128(4):602-8. PubMed ID: 15457162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of supplementing cardioplegic solution with deferoxamine on reperfused human myocardium.
    Ferreira R; Burgos M; Milei J; Llesuy S; Molteni L; Hourquebie H; Boveris A
    J Thorac Cardiovasc Surg; 1990 Nov; 100(5):708-14. PubMed ID: 2232833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of a novel thromboxane antagonist, BAY-U3405, on canine myocardial damage after coronary artery occlusion and reperfusion.
    Fiedler VB; Perzborn E; Seuter F
    Pharmacotherapy; 1991; 11(1):77-84. PubMed ID: 2020615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.